| Omar S Faridi, MD | |
|
202 Cherry St, Milford, CT 06460-3502 | |
| (203) 878-1236 | |
| (203) 874-8838 |
| Full Name | Omar S Faridi |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 202 Cherry St, Milford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437358900 | NPI | - | NPPES |
| 004068649 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 050495 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cornell Scott Hill Health Corporation | 3072418359 | 143 |
| Eye Physicians And Surgeons, Pc | 9133161128 | 10 |
News Archive
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
The farming industry in Britain has been dealt another blow with the confirmation of another case of blue tongue disease.
The University of Texas System has launched a groundbreaking clinical trials network to ensure drugs and therapies developed by researchers at UT institutions get to patients faster and are effective.
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
› Verified 2 days ago
| Entity Name | Cornell Scott Hill Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902921380 PECOS PAC ID: 3072418359 Enrollment ID: O20031201000145 |
News Archive
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
The farming industry in Britain has been dealt another blow with the confirmation of another case of blue tongue disease.
The University of Texas System has launched a groundbreaking clinical trials network to ensure drugs and therapies developed by researchers at UT institutions get to patients faster and are effective.
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
› Verified 2 days ago
| Entity Name | Eye Physicians & Surgeons, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326188111 PECOS PAC ID: 9133161128 Enrollment ID: O20050601000049 |
News Archive
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
The farming industry in Britain has been dealt another blow with the confirmation of another case of blue tongue disease.
The University of Texas System has launched a groundbreaking clinical trials network to ensure drugs and therapies developed by researchers at UT institutions get to patients faster and are effective.
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omar S Faridi, MD 202 Cherry St, Milford, CT 06460-3502 Ph: (203) 878-1236 | Omar S Faridi, MD 202 Cherry St, Milford, CT 06460-3502 Ph: (203) 878-1236 |
News Archive
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
The farming industry in Britain has been dealt another blow with the confirmation of another case of blue tongue disease.
The University of Texas System has launched a groundbreaking clinical trials network to ensure drugs and therapies developed by researchers at UT institutions get to patients faster and are effective.
Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.
› Verified 2 days ago
Charles J Oestrich, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 63 Broad St, Milford, CT 06460 Phone: 203-877-6676 Fax: 203-878-0636 | |
Philip Jay Silverstone, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 202 Cherry St, Milford, CT 06460 Phone: 203-878-1236 Fax: 203-876-5196 | |
Martin Robert Shapiro, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Cherry St, Milford, CT 06460 Phone: 203-878-1236 Fax: 203-876-5196 | |
Dr. David Harris Levinson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Cherry St, Milford, CT 06460 Phone: 203-878-1236 Fax: 203-874-8838 | |
Seth William Meskin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Cherry St, Milford, CT 06460 Phone: 203-878-1236 Fax: 203-874-8838 | |
Darron Adam Bacal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Cherry St, Milford, CT 06460 Phone: 203-878-1236 Fax: 203-876-5196 |